AC
Armistice Capital Portfolio holdings
AUM
$2.64B
1-Year Return
0.99%
This Quarter Return
+4.88%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$3.82B
AUM Growth
+$1.18M
(+0.03%)
Cap. Flow
-$187M
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
31.93%
Holding
328
New
76
Increased
87
Reduced
63
Closed
72
Top Buys
| 1 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
$33.5M |
| 2 |
FIVE9
FIVN
|
$33.1M |
| 3 |
Domino's
DPZ
|
$32.9M |
| 4 |
Incyte
INCY
|
$28.6M |
| 5 |
Humana
HUM
|
$23.6M |
Top Sells
| 1 |
Neurocrine Biosciences
NBIX
|
$91.8M |
| 2 |
Exact Sciences
EXAS
|
$59.2M |
| 3 |
Sanofi
SNY
|
$53M |
| 4 |
Keurig Dr Pepper
KDP
|
$49.6M |
| 5 |
GSK
GSK
|
$39.9M |
Sector Composition
| 1 | Healthcare | 68.01% |
| 2 | Consumer Discretionary | 11.66% |
| 3 | Consumer Staples | 8.76% |
| 4 | Technology | 8.5% |
| 5 | Communication Services | 1.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Mobix Labs
MOBX
$58.2M
| $2.48M | 0.04% |
+2,336,000
| New | +$2.48M |
|
152
Zegna
ZGN
$2.29B
| $2.38M | 0.04% |
242,000
+2,765
| +1% | +$27.2K |
|
|
CMRX
153
DELISTED
Chimerix, Inc.
CMRX
| $2.05M | 0.03% |
2,208,000
-16,000
| -0.7% | -$14.9K |
|
|
VINC
154
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $1.94M | 0.03% |
135,200
+35,800
| +36% | +$513K |
|
155
Surrozen
SRZN
$105M
| $1.67M | 0.03% |
139,000
-51,000
| -27% | -$611K |
|
156
Nike
NKE
$109B
| $1.59M | 0.03% |
+17,986
| New | +$1.59M |
|
157
Cartesian Therapeutics
RNAC
$277M
| $1.59M | 0.03% |
+98,565
| New | +$1.59M |
|
|
BCLI
158
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $1.59M | 0.03% |
459,844
-68,000
| -13% | -$235K |
|
|
EVAX
159
Evaxion A/S American Depositary Share
EVAX
$18.4M
| $1.5M | 0.02% |
96,600
+18,200
| +23% | +$283K |
|
160
Iterum Therapeutics
ITRM
$30.3M
| $1.46M | 0.02% |
+1,340,000
| New | +$1.46M |
|
161
Cosmos Holdings
COSM
$19.6M
| $1.45M | 0.02% |
+1,658,850
| New | +$1.45M |
|
|
CANF
162
Can-Fite BioPharma
CANF
$10.3M
| $1.31M | 0.02% |
650,000
+131,147
| +25% | +$264K |
|
163
Nektar Therapeutics
NKTR
$764M
| $1.3M | 0.02% |
66,667
+10,934
| +20% | +$213K |
|
164
Worksport
WKSP
$22.6M
| $1.28M | 0.02% |
299,300
+78,624
| +36% | +$336K |
|
|
AIM
165
AIM ImmunoTech Inc.
AIM
$6.72M
| $1.17M | 0.02% |
43,300
+2,520
| +6% | +$68K |
|
|
AWH
166
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $1.02M | 0.02% |
1,256,000
+788,000
| +168% | +$638K |
|
167
Monster Beverage
MNST
$61B
| $969K | 0.02% |
+18,568
| New | +$969K |
|
168
GE Aerospace
GE
$296B
| $938K | 0.02% |
+4,974
| New | +$938K |
|
169
Illumina
ILMN
$15.7B
| $930K | 0.01% |
+7,128
| New | +$930K |
|
170
Accuray
ARAY
$170M
| $900K | 0.01% |
500,000
| – | – |
|
|
PPBT
171
Purple Biotech
PPBT
$2M
| $877K | 0.01% |
158,000
+90,100
| +133% | +$500K |
|
172
Moleculin Biotech
MBRX
$11.4M
| $824K | 0.01% |
290,000
+134,000
| +86% | +$381K |
|
173
Inhibikase Therapeutics
IKT
$124M
| $814K | 0.01% |
626,500
+36,925
| +6% | +$48K |
|
|
APTO
174
DELISTED
Aptose Biosciences, Inc.
APTO
| $776K | 0.01% |
62,933
+5,833
| +10% | +$71.9K |
|
175
LM Funding America
LMFA
$16.6M
| $737K | 0.01% |
+277,000
| New | +$737K |
|